Adrenaline rush: The role of adrenergic receptors in stimulant-induced behaviors

Molecular Pharmacology

Volumn 85, Issue 4, 2014, Pages 640-650

  Schmidt, Karl T ^a   Weinshenker, David ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; AMPHETAMINE; COCAINE; DEXAMPHETAMINE; PRAZOSIN; PROPRANOLOL; PSYCHOSTIMULANT AGENT;

ADRENERGIC STIMULATION; ANXIETY; AVERSION; BEHAVIOR; BEHAVIOR DISORDER; DISCRIMINATIVE STIMULUS; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; DRUG SELF ADMINISTRATION; DRUG TARGETING; FEAR; HUMAN; INTRACELLULAR SIGNALING; LOCOMOTION; MOTOR ACTIVITY; NEUROANATOMY; NONHUMAN; NORADRENERGIC SYSTEM; PHARMACOLOGICAL STIMULATION; PLACE PREFERENCE; PRIORITY JOURNAL; REVIEW; THERAPY;

AMPHETAMINE; ANIMALS; ANXIETY; AVOIDANCE LEARNING; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; COCAINE; CONDITIONING, CLASSICAL; DISCRIMINATION (PSYCHOLOGY); MOTOR ACTIVITY; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA; SELF ADMINISTRATION; SIGNAL TRANSDUCTION;

EID: 84896881576     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.090118     Document Type: Review

References (143)

1. Aghajanian GK and Van Der Maelen CP (1982) alpha 2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: intracellular studies in vivo. Science 215:1394-1396. (Pubitemid 12129720)
2. Aguilar MA, Rodríguez-Arias M, and Miñarro J (2009) Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res Brain Res Rev 59:253-277.
3. Al-Hasani R, McCall JG, Foshage AM, and Bruchas MR (2013) Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism. Neuropsychopharmacology 38:2484-2497.
4. Alsene KM, Fallace K, and Bakshi VP (2010) Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine. Neuropsychopharmacology 35:2346-2356.
5. Asin KE and Wirtshafter D (1985) Clonidine produces a conditioned place preference in rats. Psychopharmacology (Berl) 85:383-385. (Pubitemid 15123118)
6. Auclair A, Cotecchia S, Glowinski J, and Tassin JP (2002) D-amphetamine fails to increase extracellular dopamine levels in mice lacking alpha 1b-adrenergic receptors: relationship between functional and nonfunctional dopamine release. J Neurosci 22:9150-9154. (Pubitemid 35356155)
7. Auclair A, Drouin C, Cotecchia S, Glowinski J, and Tassin JP (2004) 5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci 20:3073-3084. (Pubitemid 40007302)
8. Baillie GS, Sood A, McPhee I, Gall I, Perry SJ, Lefkowitz RJ, and Houslay MD (2003) beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci USA 100:940-945. (Pubitemid 36183934)
9. Beaulieu J-M, Gainetdinov RR, and Caron MG (2009) Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49:327-347.
10. Bernardi RE and Lattal KM (2010) A role for alpha-adrenergic receptors in extinction of conditioned fear and cocaine conditioned place preference. Behav Neurosci 124:204-210.
11. Bernardi RE and Lattal KM (2012a) Post-conditioning propranolol disrupts cocaine sensitization. Pharmacol Biochem Behav 102:515-519.
12. Bernardi RE and Lattal KM (2012b) Prazosin differentially affects extinction of cocaine conditioned place preference on the basis of dose and initial preference. Neuroreport 23:1048-1051.
13. Bernardi RE, Lattal KM, and Berger SP (2006) Postretrieval propranolol disrupts a cocaine conditioned place preference. Neuroreport 17:1443-1447. (Pubitemid 44299391)
14. Bernardi RE, Ryabinin AE, Berger SP, and Lattal KM (2009) Post-retrieval disruption of a cocaine conditioned place preference by systemic and intrabasolateral amygdala beta2- and alpha1-adrenergic antagonists. Learn Mem 16:777-789.
15. Bilski AJ, Halliday SE, Fitzgerald JD, and Wale JL (1983) The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118, 551). J Cardiovasc Pharmacol 5:430-437. (Pubitemid 13080761)
16. Blanc G, Trovero F, Vezina P, Hervé D, Godeheu AM, Glowinski J, and Tassin JP (1994) Blockade of prefronto-cortical alpha 1-adrenergic receptors prevents locomotor hyperactivity induced by subcortical D-amphetamine injection. Eur J Neurosci 6:293-298.
17. Boer R, Grassegger A, Schudt C, and Glossmann H (1989) (+)-Niguldipine binds with very high-affinity to CA-2+ channels and to a subtype of alpha1-1-adrenoceptors. Eur J Pharmacol 172:131-145. (Pubitemid 19230192)
18. Brown ZJ, Nobrega JN, and Erb S (2011) Central injections of noradrenaline induce reinstatement of cocaine seeking and increase c-fos mRNA expression in the extended amygdala. Behav Brain Res 217:472-476.
19. Brown ZJ, Tribe E, D'souza NA, and Erb S (2009) Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat. Psychopharmacology (Berl) 203:121-130.
20. Buffalari DM, Baldwin CK, and See RE (2012) Treatment of cocaine withdrawal anxiety with guanfacine: relationships to cocaine intake and reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) 223:179-190.
21. Carter AJ (1997) Hippocampal noradrenaline release in awake, freely moving rats is regulated by alpha-2 adrenoceptors but not by adenosine receptors. J Pharmacol Exp Ther 281:648-654. (Pubitemid 27203795)
22. Cervo L, Rossi C, and Samanin R (1993) Clonidine-induced place preference is mediated by alpha 2-adrenoceptors outside the locus coeruleus. Eur J Pharmacol 238:201-207. (Pubitemid 23214432)
23. Clifford PS, Davis KW, Elliott AE, and Wellman PJ (2007) Effects of ICV administration of the alpha1A-adrenoceptor antagonist 5-methylurapidil on concurrent measures of eating and locomotion after cocaine in the rat. Life Sci 81:1059-1065. (Pubitemid 47418844)
24. Colpaert FC, Niemegeers CJE, and Janssen PAJ (1976) Cocaine cue in rats as it relates to subjective drug effects: a preliminary report. Eur J Pharmacol 40:195-199. (Pubitemid 8007553)
25. Colpaert FC, Niemegeers CJE, and Janssen PAJ (1979) Discriminative stimulus properties of cocaine: neuropharmacological characteristics as derived from stimulus generalization experiments. Pharmacol Biochem Behav 10:535-546. (Pubitemid 9191982)
26. Colussi-Mas J, Panayi F, Scarna H, Renaud B, Bérod A, and Lambás-Señas L (2005) Blockade of beta-adrenergic receptors prevents amphetamine-induced behavioural sensitization in rats: a putative role of the bed nucleus of the stria terminalis. Int J Neuropsychopharmacol 8:569-581. (Pubitemid 41400888)
27. Conrad KL, Davis AR, Silberman Y, Sheffler DJ, Shields AD, Saleh SA, Sen N, Matthies HJG, Javitch JA, and Lindsley CW et al. (2012) Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes. Neuropsychopharmacology 37:2253-2266.
28. Consoli D, Leggio GM, Mazzola C, Micale V, and Drago F (2007) Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs? Eur J Pharmacol 573:139-147. (Pubitemid 47464213)
29. Daaka Y, Luttrell LM, and Lefkowitz RJ (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390:88-91. (Pubitemid 27494762)
30. Darracq L, Blanc G, Glowinski J, and Tassin JP (1998) Importance of the noradrenalinedopamine coupling in the locomotor activating effects of D-amphetamine. J Neurosci 18:2729-2739. (Pubitemid 28141818)
31. Davis AR, Shields AD, Brigman JL, Norcross M, McElligott ZA, Holmes A, and Winder DG (2008) Yohimbine impairs extinction of cocaine-conditioned place preference in an alpha2-adrenergic receptor independent process. Learn Mem 15:667-676.
32. Davis WM and Smith SG (1977) Catecholaminergic mechanisms of reinforcement: direct assessment by drug-self-administration. Life Sci 20:483-492. (Pubitemid 8051882)
33. Dickinson SL, Gadie B, and Tulloch IF (1988) Alpha 1- and alpha 2-adrenoreceptor antagonists differentially influence locomotor and stereotyped behaviour induced by d-amphetamine and apomorphine in the rat. Psychopharmacology (Berl) 96:521-527. (Pubitemid 19002230)
34. D'Mello GD (1982) Comparison of the discriminative stimulus properties of clonidine and amphetamine in rats. Neuropharmacology 21:763-769. (Pubitemid 12042206)
35. Doucet EL, Bobadilla A-C, Houades V, Lanteri C, Godeheu G, Lanfumey L, Sara SJ, and Tassin J-P (2013) Sustained impairment of a2A-adrenergic autoreceptor signaling mediates neurochemical and behavioral sensitization to amphetamine. Biol Psychiatry 74:90-98.
36. Drouin C, Darracq L, Trovero F, Blanc G, Glowinski J, Cotecchia S, and Tassin JP (2002) Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates. J Neurosci 22:2873-2884. (Pubitemid 37465836)
37. Ecke LE, Elmer GI, and Suto N (2012) Cocaine self-administration is not dependent upon mesocortical a1 noradrenergic signaling. Neuroreport 23:325-330.
38. Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, and Stewart J (2000) Alpha-2 adrenergic receptor agonists block stress-induced reinstatement of cocaine seeking. Neuropsychopharmacology 23:138-150. (Pubitemid 30406898)
39. Ercil NE and France CP (2003) Amphetamine-like discriminative stimulus effects of ephedrine and its stereoisomers in pigeons. Exp Clin Psychopharmacol 11:3-8. (Pubitemid 36237337)
40. Feuerstein TJ, Hertting G, and Jackisch R (1985) Endogenous noradrenaline as modulator of hippocampal serotonin (5-HT)-release. Dual effects of yohimbine, rauwolscine and corynanthine as alpha-adrenoceptor antagonists and 5-HT-receptor agonists. Naunyn Schmiedebergs Arch Pharmacol 329:216-221. (Pubitemid 15074511)
41. File SE (1986) Aversive and appetitive properties of anxiogenic and anxiolytic agents. Behav Brain Res 21:189-194. (Pubitemid 16012181)
42. Fox HC, Seo D, Tuit K, Hansen J, Kimmerling A, Morgan PT, and Sinha R (2012) Guanfacine effects on stress, drug craving and prefrontal activation in cocaine dependent individuals: preliminary findings. J Psychopharmacol 26:958-972.
43. Fricks-Gleason AN and Marshall JF (2008) Post-retrieval beta-adrenergic receptor blockade: effects on extinction and reconsolidation of cocaine-cue memories. Learn Mem 15:643-648.
44. Gaval-Cruz M and Weinshenker D (2009) Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv 9:175-187.
45. Gobert A, Rivet JM, Audinot V, Newman-Tancredi A, Cistarelli L, and Millan MJ (1998) Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release. Neuroscience 84:413-429. (Pubitemid 28122907)
46. Goetz AS, King HK, Ward SDC, True TA, Rimele TJ, and Saussy DL, Jr (1995) BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors. Eur J Pharmacol 272:R5-R6.
47. Goldberg SR and Gonzalez FA (1976) Effects of propranolol on behavior maintained under fixed-ratio schedules of cocaine injection or food presentation in squirrel monkeys. J Pharmacol Exp Ther 198:626-634.
48. Hanft G and Gross G (1989) Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br J Pharmacol 97:691-700. (Pubitemid 19168700)
49. Haile CN, De La Garza R, 2nd, Mahoney JJ, 3rd, Nielsen DA, Kosten TR, and Newton TF (2012) The impact of disulfiram treatment on the reinforcing effects of cocaine: a randomized clinical trial. PLoS ONE 7:e47702.
50. Hall FS, Sora I, Drgonova J, Li XF, Goeb M, and Uhl GR (2004) Molecular mechanisms underlying the rewarding effects of cocaine. Ann N Y Acad Sci 1025:47-56. (Pubitemid 39643844)
51. Harris GC and Aston-Jones G (1993) Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats. Psychopharmacology (Berl) 113:131-136. (Pubitemid 23341057)
52. Harris GC, Hedaya MA, Pan WJ, and Kalivas P (1996) beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology 14:195-204.
53. Highfield D, Yap J, Grimm JW, Shalev U, and Shaham Y (2001) Repeated lofexidine treatment attenuates stress-induced, but not drug cues-induced reinstatement of a heroin-cocaine mixture (speedball) seeking in rats. Neuropsychopharmacology 25:320-331. (Pubitemid 32777784)
54. Howell LL and Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178-185.
55. Jimenez-Rivera CA, Feliu-Mojer M, and Vazquez-Torres R (2006) Alpha-noradrenergic receptors modulate the development and expression of cocaine sensitization. Ann N Y Acad Sci 1074:390-402. (Pubitemid 44532844)
56. Jobes ML, Ghitza UE, Epstein DH, Phillips KA, Heishman SJ, and Preston KL (2011) Clonidine blocks stress-induced craving in cocaine users. Psychopharmacology (Berl) 218:83-88.
57. Johanson CE and Barrett JE (1993) The discriminative stimulus effects of cocaine in pigeons. J Pharmacol Exp Ther 267:1-8. (Pubitemid 23324981)
58. Juhila J, Honkanen A, Sallinen J, Haapalinna A, Korpi ER, and Scheinin M (2005) alpha (2A)-Adrenoceptors regulate d-amphetamine-induced hyperactivity and behavioural sensitization in mice. Eur J Pharmacol 517:74-83. (Pubitemid 40910256)
59. Kampman KM, Volpicelli JR, Mulvaney F, Alterman AI, Cornish J, Gariti P, Cnaan A, Poole S, Muller E, and Acosta T et al. (2001) Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend 63:69-78. (Pubitemid 32288735)
60. Kleven MS and Koek W (1997) Discriminative stimulus properties of cocaine: enhancement by beta-adrenergic receptor antagonists. Psychopharmacology (Berl) 131:307-312. (Pubitemid 27283593)
61. Kleven MS and Koek W (1998) Discriminative stimulus properties of cocaine: enhancement by monoamine reuptake blockers. J Pharmacol Exp Ther 284:1015-1025. (Pubitemid 28130830)
62. Kongyingyoes B, Jänicke B, and Coper H (1988) The influence of brain catecholamines on 'drug taking behaviour' relative to oral self-administration of d-amphetamine by rats. Drug Alcohol Depend 22:223-233. (Pubitemid 19008762)
63. Kupferschmidt DA, Tribe E, and Erb S (2009) Effects of repeated yohimbine on the extinction and reinstatement of cocaine seeking. Pharmacol Biochem Behav 91:473-480.
64. La Lumiere RT, Niehoff KE, and Kalivas PW (2010) The infralimbic cortex regulates the consolidation of extinction after cocaine self-administration. Learn Mem 17:168-175.
65. Lee B, Tiefenbacher S, Platt DM, and Spealman RD (2004) Pharmacological blockade of alpha2-adrenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 29:686-693. (Pubitemid 38402476)
66. Leri F, Flores J, Rodaros D, and Stewart J (2002) Blockade of stress-induced but not cocaine-induced reinstatement by infusion of noradrenergic antagonists into the bed nucleus of the stria terminalis or the central nucleus of the amygdala. JNeurosci 22:5713-5718. (Pubitemid 35386493)
67. Lin Y and Smrcka AV (2011) Understanding molecular recognition by G protein βγ subunits on the path to pharmacological targeting. Mol Pharmacol 80:551-557.
68. Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, and Caretta H (2010) Involvement of noradrenergic neurotransmission in the stress-but not cocaineinduced reinstatement of extinguished cocaine-induced conditioned place preference in mice: role for β-2 adrenergic receptors. Neuropsychopharmacology 35:2165-2178.
69. Mariani JJ and Levin FR (2012) Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am 35:425-439.
70. Marinelli M and White FJ (2000) Enhanced vulnerability to cocaine self-administration is associated with elevated impulse activity of midbrain dopamine neurons. J Neurosci 20:8876-8885.
71. McKenna ML and Ho BT (1980) The role of dopamine in the discriminative stimulus properties of cocaine. Neuropharmacology 19:297-303. (Pubitemid 10154973)
72. Mefford IN (1988) Epinephrine in mammalian brain. Prog Neuropsychopharmacol Biol Psychiatry 12:365-388.
73. Meitzen J, Luoma JI, Stern CM, and Mermelstein PG (2011) β1-Adrenergic receptors activate two distinct signaling pathways in striatal neurons. J Neurochem 116:984-995.
74. Millan MJ, Newman-Tancredi A, Audinot V, Cussac D, Lejeune F, Nicolas JP, Cogé F, Galizzi JP, Boutin JA, and Rivet JM et al. (2000) Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha (2)-adrenergic receptors (AR) s, serotonin (5-HT) (1A), 5-HT (1B), 5-HT (1D) and dopamine D (2) and D (3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35:79-95. (Pubitemid 30036185)
75. Minneman KP, Theroux TL, Hollinger S, Han CD, and Esbenshade TA (1994) Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes. Mol Pharmacol 46:929-936. (Pubitemid 24364107)
76. Mitrano DA, Schroeder JP, Smith Y, Cortright JJ, Bubula N, Vezina P, and Weinshenker D (2012) a-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology 37:2161-2172.
77. Morales L, Perez-Garcia C, and Alguacil LF (2001) Effects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodents. Br J Pharmacol 133:172-178. (Pubitemid 32500464)
78. Morrow AL and Creese I (1986) Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Mol Pharmacol 29:321-330. (Pubitemid 16078479)
79. Mueller D and Cahill SP (2010) Noradrenergic modulation of extinction learning and exposure therapy. Behav Brain Res 208:1-11.
80. Munzar P and Goldberg SR (1999) Noradrenergic modulation of the discriminativestimulus effects of methamphetamine in rats. Psychopharmacology (Berl) 143:293-301. (Pubitemid 29204984)
81. Newton TF, De La Garza R, 2nd, Brown G, Kosten TR, Mahoney JJ, 3rd, and Haile CN (2012) Noradrenergic α1 receptor antagonist treatment attenuates positive subjective effects of cocaine in humans: a randomized trial. PLoS ONE 7:e30854.
82. O'Donnell SR and Wanstall JC (1980) Evidence that ICI 118, 551 is a potent, highly Beta 2-selective adrenoceptor antagonist and can be used to characterize Betaadrenoceptor populations in tissues. Life Sci 27:671-677. (Pubitemid 11235872)
83. Otis JM, Dashew KB, and Mueller D (2013) Neurobiological dissociation of retrieval and reconsolidation of cocaine-associated memory. J Neurosci 33:1271-1281a.
84. Otis JM, Fitzgerald MK, and Mueller D (2014) Inhibition of hippocampal β-adrenergic receptors impairs retrieval but not reconsolidation of cocaine-associated memory and prevents subsequent reinstatement. Neuropsychopharmacology 39:303-310.
85. Otis JM and Mueller D (2011) Inhibition of β-adrenergic receptors induces a persistent deficit in retrieval of a cocaine-associated memory providing protection against reinstatement. Neuropsychopharmacology 36:1912-1920.
86. Ouyang M, Young MB, Lestini MM, Schutsky K, and Thomas SA (2012) Redundant catecholamine signaling consolidates fear memory via phospholipase C. J Neurosci 32:1932-1941.
87. Pellow S, Chopin P, File SE, and Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149-167. (Pubitemid 16239568)
88. Platt DM, Rowlett JK, and Spealman RD (2007) Noradrenergic mechanisms in cocaine-induced reinstatement of drug seeking in squirrel monkeys. J Pharmacol Exp Ther 322:894-902. (Pubitemid 47105772)
89. Preston KL, Bigelow GE, and Liebson IA (1985) Self-administration of clonidine, oxazepam, and hydromorphone by patients undergoing methadone detoxification. Clin Pharmacol Ther 38:219-227. (Pubitemid 16248176)
90. Richardson NR and Roberts DCS (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66:1-11. (Pubitemid 26180064)
91. Risner ME and Jones BE (1976) Role of noradrenergic and dopaminergic processes in amphetamine self-administration. Pharmacol Biochem Behav 5:477-482. (Pubitemid 8011031)
92. Risner ME and Jones BE (1980) Intravenous self-administration of cocaine and norcocaine by dogs. Psychopharmacology (Berl) 71:83-89. (Pubitemid 11226291)
93. Robinson TE and Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103-114. (Pubitemid 32099343)
94. Robledo P, Balerio G, Berrendero F, and Maldonado R (2004) Study of the behavioural responses related to the potential addictive properties of MDMA in mice. Naunyn Schmiedebergs Arch Pharmacol 369:338-349. (Pubitemid 38372940)
95. Rowlett JK, Platt DM, and Spealman RD (2004) Cocaine-like discriminative stimulus effects of heroin: modulation by selective monoamine transport inhibitors. J Pharmacol Exp Ther 310:342-348. (Pubitemid 38812729)
96. Rudoy CA, Reyes A-RS, and Van Bockstaele EJ (2009) Evidence for beta1-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal. Neuropsychopharmacology 34:1135-1148.
97. Rudoy CA and Van Bockstaele EJ (2007) Betaxolol, a selective beta (1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats. Prog Neuropsychopharmacol Biol Psychiatry 31:1119-1129. (Pubitemid 46810110)
98. Sadalge A, Coughlin L, Fu H, Wang B, Valladares O, Valentino R, and Blendy JA (2003) alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity. Mol Psychiatry 8:664-672. (Pubitemid 36976299)
99. Sahraei H, Ghazzaghi H, Zarrindast MR, Ghoshooni H, Sepehri H, and Haeri-Rohan A (2004) The role of alpha-adrenoceptor mechanism (s) in morphine-induced conditioned place preference in female mice. Pharmacol Biochem Behav 78:135-141. (Pubitemid 38670522)
100. Sallinen J, Link RE, Haapalinna A, Viitamaa T, Kulatunga M, Sjoholm B, MacDonald E, Pelto Huikko M, Leino T, Barsh GS, Kobilka BK, and Scheinin M (1997) Genetic alteration of alpha (2C)-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha (2)-adrenoceptor agonist. Mol Pharmacol 51:36-46. (Pubitemid 27049543)
101. Salomon L, Lanteri C, Glowinski J, and Tassin JP (2006) Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci USA 103:7476-7481. (Pubitemid 43727858)
102. Sasaki JE, Tatham TA, and Barrett JE (1995) The discriminative stimulus effects of methamphetamine in pigeons. Psychopharmacology (Berl) 120:303-310.
103. Schank JR, Liles LC, and Weinshenker D (2008) Norepinephrine signaling through beta-adrenergic receptors is critical for expression of cocaine-induced anxiety. Biol Psychiatry 63:1007-1012.
104. Schechter MD and Cook PG (1975) Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats. Psychopharmacology (Berl) 42:185-193.
105. Schroeder JP, Alisha Epps S, Grice TW, and Weinshenker D (2013) The selective dopamine b-hydroxylase inhibitor nepicastat attenuates multiple aspects of cocaine-seeking behavior. Neuropsychopharmacology 38:1032-1038.
106. Schutsky K, Ouyang M, Castelino CB, Zhang L, and Thomas SA (2011a) Stress and glucocorticoids impair memory retrieval via b2-adrenergic, Gi/o-coupled suppression of cAMP signaling. J Neurosci 31:14172-14181.
107. Schutsky K, Ouyang M, and Thomas SA (2011b) Xamoterol impairs hippocampusdependent emotional memory retrieval via Gi/o-coupled b2-adrenergic signaling. Learn Mem 18:598-604.
108. Schwartz DD and Clark TP (1998) Selectivity of atipamezole, yohimbine and tolazoline for alpha-2 adrenergic receptor subtypes: implications for clinical reversal of alpha-2 adrenergic receptor mediated sedation in sheep. J Vet Pharmacol Ther 21:342-347. (Pubitemid 28488097)
109. Shearman GT, Hynes M, and Lal H (1981) Self-administration of clonidine by the rat. Prog Clin Biol Res 71:259-276.
110. Shepard JD, Bossert JM, Liu SY, and Shaham Y (2004) The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol Psychiatry 55:1082-1089. (Pubitemid 38680560)
111. Shorter D, Lindsay JA, and Kosten TR (2013) The alpha-1 adrenergic antagonist doxazosin for treatment of cocaine dependence: A pilot study. Drug Alcohol Depend 131:66-70.
112. Simmons DL, Mandt BH, Ng CMC, Richards TL, Yamamoto DJ, Zahniser NR, and Allen RM (2013) Low- and high-cocaine locomotor responding rats differ in reinstatement of cocaine seeking and striatal mGluR5 protein expression. Neuropharmacology 75:347-355.
113. Smith RJ and Aston-Jones G (2011) a (2) Adrenergic and imidazoline receptor agonists prevent cue-induced cocaine seeking. Biol Psychiatry 70:712-719.
114. Snoddy AM and Tessel RE (1985) Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice. Eur J Pharmacol 116:221-228. (Pubitemid 16191811)
115. Spealman RD (1995) Noradrenergic involvement in the discriminative stimulus effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 275:53-62.
116. Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, and Uhl GR (1998) Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 95:7699-7704. (Pubitemid 28293316)
117. Stone EA, Lin Y, Rosengarten H, Kramer HK, and Quartermain D (2003) Emerging evidence for a central epinephrine-innervated alpha 1-adrenergic system that regulates behavioral activation and is impaired in depression. Neuropsychopharmacology 28:1387-1399. (Pubitemid 41070873)
118. Stone EA, Zhang Y, Rosengarten H, Yeretsian J, and Quartermain D (1999) Brain alpha 1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94:1245-1252. (Pubitemid 29509689)
119. Tahsili-Fahadan P, Yahyavi-Firouz-Abadi N, Khoshnoodi MA, Motiei-Langroudi R, Tahaei SA, Ghahremani MH, and Dehpour AR (2006) Agmatine potentiates morphine-induced conditioned place preference in mice: modulation by alpha2-adrenoceptors. Neuropsychopharmacology 31:1722-1732. (Pubitemid 44106703)
120. Tzschentke TM (2007) Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12:227-462. (Pubitemid 47196347)
121. Valdez GR, Platt DM, Rowlett JK, Rüedi-Bettschen D, and Spealman RD (2007) Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms. J Pharmacol Exp Ther 323:525-533. (Pubitemid 350005110)
122. Vanderschuren LJ, Beemster P, and Schoffelmeer ANM (2003) On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization. Psychopharmacology (Berl) 169:176-185. (Pubitemid 37129969)
123. Vaughn LK, Mantsch JR, Vranjkovic O, Stroh G, Lacourt M, Kreutter M, and Hillard CJ (2012) Cannabinoid receptor involvement in stress-induced cocaine reinstatement: potential interaction with noradrenergic pathways. Neuroscience 204:117-124.
124. Villégier AS, Drouin C, Bizot JC, Marien M, Glowinski J, Colpaërt F, and Tassin JP (2003) Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice. Synapse 50:277-284. (Pubitemid 37420582)
125. Vranjkovic O, Hang S, Baker DA, and Mantsch JR (2012) β-adrenergic receptor mediation of stress-induced reinstatement of extinguished cocaine-induced conditioned place preference in mice: roles for β1 and β2 adrenergic receptors. J Pharmacol Exp Ther 342:541-551.
126. Wee S, Mandyam CD, Lekic DM, and Koob GF (2008) Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access. Eur Neuropsychopharmacol 18:303-311. (Pubitemid 351246717)
127. Weerts EM and Griffiths RR (1999) Evaluation of the intravenous reinforcing effects of clonidine in baboons. Drug Alcohol Depend 53:207-214. (Pubitemid 29027990)
128. Weinshenker D, Miller NS, Blizinsky K, Laughlin ML, and Palmiter RD (2002) Mice with chronic norepinephrine deficiency resemble amphetamine- sensitized animals. Proc Natl Acad Sci USA 99:13873-13877. (Pubitemid 35215473)
129. Weinshenker D and Schroeder JP (2007) There and back again: a tale of norepinephrine and drug addiction. Neuropsychopharmacology 32:1433-1451. (Pubitemid 46920149)
130. Wellman P, Ho D, Cepeda-Benito A, Bellinger L, and Nation J (2002) Cocaineinduced hypophagia and hyperlocomotion in rats are attenuated by prazosin. Eur J Pharmacol 455:117-126. (Pubitemid 35351606)
131. Wenzel JM, Cotton SW, Dominguez HM, Lane JE, Shelton K, Su ZI, and Ettenberg A (2014) Noradrenergic β-receptor antagonism within the central nucleus of the amygdala or the bed nucleus of the stria terminalis attenuates the negative/anxiogenic effects of cocaine. J Neurosci, in press.
132. West WB, Van Groll BJ, and Appel JB (1995) Stimulus effects of d-amphetamine II: DA, NE, and 5-HT mechanisms. Pharmacol Biochem Behav 51:69-76.
133. Wilson MC and Schuster CR (1974) Aminergic influences on intravenous cocaine self-administration by Rhesus monkeys. Pharmacol Biochem Behav 2:563-571.
134. Wood DM, Lal H, Yaden S, and Emmett-Oglesby MW (1985) One-way generalization of clonidine to the discriminative stimulus produced by cocaine. Pharmacol Biochem Behav 23:529-533. (Pubitemid 16191745)
135. Woolverton WL (1987) Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys. Pharmacol Biochem Behav 26:835-839.
136. Woolverton WL, Wessinger WD, and Balster RL (1982) Reinforcing properties of clonidine in rhesus monkeys. Psychopharmacology (Berl) 77:17-23. (Pubitemid 12091350)
137. Yamamoto H, Yoo SK, Nishita M, Kikuchi A, and Minami Y (2007) Wnt5a modulates glycogen synthase kinase 3 to induce phosphorylation of receptor tyrosine kinase Ror2. Genes Cells 12:1215-1223. (Pubitemid 350042419)
138. Yokel RA and Wise RA (1978) Amphetamine-type reinforcement by dopaminergic agonists in the rat. Psychopharmacology (Berl) 58:289-296. (Pubitemid 8393430)
139. Young R and Glennon RA (2009) S (-) Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats. Psychopharmacology (Berl) 203:369-382.
140. Zarrindast MR, Bahreini T, and Adl M (2002) Effect of imipramine on the expression and acquisition of morphine-induced conditioned place preference in mice. Pharmacol Biochem Behav 73:941-949. (Pubitemid 35246243)
141. Zhang XY and Kosten TA (2005) Prazosin, an alpha-1 adrenergic antagonist, reduces cocaine-induced reinstatement of drug-seeking. Biol Psychiatry 57:1202-1204. (Pubitemid 40615783)
142. Zhang XY and Kosten TA (2007) Previous exposure to cocaine enhances cocaine self-administration in an alpha 1-adrenergic receptor dependent manner. Neuropsychopharmacology 32:638-645.
143. Zhong HY and Minneman KP (1999) Differential activation of mitogen-activated protein kinase pathways in PC12 cells by closely related alpha1-adrenergic receptor subtypes. J Neurochem 72:2388-2396. (Pubitemid 29242189)